ENFN Stock Overview
Enfusion, Inc. provides software-as-a-service solutions for investment management industry in the United States, Europe, the Middle East, Africa, and the Asia Pacific.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 5/6 |
Past Performance | 3/6 |
Financial Health | 6/6 |
Dividends | 0/6 |
Enfusion, Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$9.42 |
52 Week High | US$11.56 |
52 Week Low | US$7.37 |
Beta | 1.01 |
1 Month Change | 3.52% |
3 Month Change | 11.74% |
1 Year Change | 16.30% |
3 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | -52.45% |
Recent News & Updates
Recent updates
Is Now An Opportune Moment To Examine Enfusion, Inc. (NYSE:ENFN)?
Mar 13Capital Allocation Trends At Enfusion (NYSE:ENFN) Aren't Ideal
Feb 19Enfusion: Product Is Sticky And Industry Is Huge
Jan 18Calculating The Fair Value Of Enfusion, Inc. (NYSE:ENFN)
Jan 04Investors Appear Satisfied With Enfusion, Inc.'s (NYSE:ENFN) Prospects As Shares Rocket 28%
Dec 02Enfusion: Still Bullish Considering Q3 EBITDA Beat
Nov 08Why Enfusion, Inc. (NYSE:ENFN) Could Be Worth Watching
Oct 31Enfusion Faces Cross-Currents In Investment Management Software Market
Aug 24Enfusion, Inc. Just Missed Earnings - But Analysts Have Updated Their Models
Aug 11Enfusion: Multiple Catalysts
Jun 20Enfusion, Inc.'s (NYSE:ENFN) Intrinsic Value Is Potentially 32% Above Its Share Price
Mar 08Here's Why We're Not At All Concerned With Enfusion's (NYSE:ENFN) Cash Burn Situation
Feb 08Enfusion brings on Shift4 Payments' Brad Herring as CFO
Dec 19Enfusion Expands Offerings As Revenue Growth Decelerates
Oct 31Enfusion, Inc. (NYSE:ENFN) Shares Could Be 49% Below Their Intrinsic Value Estimate
Oct 18Enfusion gains after takeover report
Aug 31Enfusion gets new interim CEO
Aug 22Here's Why We're Not At All Concerned With Enfusion's (NYSE:ENFN) Cash Burn Situation
Aug 12Enfusion: A Compelling Financial SaaS Company
Jun 24Estimating The Fair Value Of Enfusion, Inc. (NYSE:ENFN)
May 10Shareholder Returns
ENFN | US Software | US Market | |
---|---|---|---|
7D | 3.4% | -0.2% | 1.0% |
1Y | 16.3% | 33.9% | 21.9% |
Return vs Industry: ENFN underperformed the US Software industry which returned 39.8% over the past year.
Return vs Market: ENFN underperformed the US Market which returned 24.9% over the past year.
Price Volatility
ENFN volatility | |
---|---|
ENFN Average Weekly Movement | 5.1% |
Software Industry Average Movement | 8.0% |
Market Average Movement | 6.0% |
10% most volatile stocks in US Market | 16.8% |
10% least volatile stocks in US Market | 3.0% |
Stable Share Price: ENFN has not had significant price volatility in the past 3 months.
Volatility Over Time: ENFN's weekly volatility (5%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1997 | 1,102 | Oleg Movchan | www.enfusion.com |
Enfusion, Inc. provides software-as-a-service solutions for investment management industry in the United States, Europe, the Middle East, Africa, and the Asia Pacific. The company provides Portfolio Management System, which generates a real-time investment book of record that consists of valuation and risk tools, which allows users to analyze aggregated or decomposed portfolio data for chief investment officers (CIOs) and portfolio managers; and Order and Execution Management System that enables portfolio managers, traders, compliance teams, and analysts to electronically communicate trade orders for a variety of asset classes, manage trade orders, and systemically enforce trading regulations and internal guidelines. It also offers Accounting/General Ledger System, a real-time accounting book of record for chief financial officers, chief operating officers, accountants, and operations teams; Enfusion Analytics System, which enables CIOs, portfolio managers, traders, and analysts to analyze portfolios through time horizons and automate customized visualized reports for internal and external stakeholders; and technology-powered and managed services.
Enfusion, Inc. Fundamentals Summary
ENFN fundamental statistics | |
---|---|
Market cap | US$1.20b |
Earnings (TTM) | US$5.72m |
Revenue (TTM) | US$174.54m |
148.0x
P/E Ratio4.9x
P/S RatioIs ENFN overvalued?
See Fair Value and valuation analysisEarnings & Revenue
ENFN income statement (TTM) | |
---|---|
Revenue | US$174.54m |
Cost of Revenue | US$57.64m |
Gross Profit | US$116.89m |
Other Expenses | US$111.18m |
Earnings | US$5.72m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 09, 2024
Earnings per share (EPS) | 0.064 |
Gross Margin | 66.97% |
Net Profit Margin | 3.28% |
Debt/Equity Ratio | 0% |
How did ENFN perform over the long term?
See historical performance and comparison